As a biostatistician who has considerable experience investigating both fixed putative source clusters and general cluster alarms, and developing methodology for these analyses, I feel I should respond to the various points raised by Coory and Jordan. I believe the authors provide a very narrow view of cluster assessment, characterizing it as testing for an excess of incident cases in a given area. A much broader view has developed over the last two decades, as described below.
General clustering issues
The idea that cluster alarms have a drawback, in that they can lead to post hoc inference (Texas sharp shooter), is of course true. However, this is a matter of degree. As noted in the excellent review by Elliott and Wakefield 1 , there is a distinction between a reported concern about the health status of an area and a post hoc claim of a particular causative association of a putative cluster identified by 'alarmists' (those who raise the alarm). One can consider these to be different ends of the spectrum with respect to inference issues. One approach that is Bayesian in flavour would be to consider that alarmists (informal experts) provide a prior distribution for the study design associated with an area and time period of study (i.e. they suggest a study window: a locale and time affected), whereas more informed formal experts have a prior that does not limit the area or time period. This generalization by formal experts can include larger study windows, alternative sources of pollution (say) and also alternative disease outcomes. The updating of these prior distributions should lead to less bias in inference. In fact this is commonly the approach used in practical cluster studies (see for example Lenihan, 2 and many other studies cited in Elliott and Wakefield1).
Second, the exploratory analysis of a study window, which is fixed in advance, can be achieved by statistical assessment of the existence of a cluster without appeal to multiple comparisons (silent or otherwise).
It is straightforward to compare a 'no cluster' model with a 'cluster' model and to assess which is more appropriate (see for example chapter 6 of Lawson 3 ).This will be achieved via assessment of the likelihood of one model over another. If there is strong statistical evidence for a cluster model, and the disease does not normally 'cluster', then this result is valuable to anyone concerned with investigation of disease risk. If a fixed point source is of concern, then a specific cluster testing procedure can be used to locate clusters. If one of these is the cluster of focus (associated with the point source) then that also provides evidence for local risk. Although this is exploratory in nature, it is valuable as part of a protocol for cluster investigation. The idea that this step should not be included in a protocol for cluster assessment seems bizarre. How does one initially assess whether any unusual or clustered risk is present without this step?
A third issue is the origin of a cluster and/or reason for its existence. There are many examples where spatial clusters of cancers have been found, but later found to consist of cases associated with family migration with variable latency periods (see, for example, Adelman et al. 2007) 4 . This is a secondary issue that must be addressed after exploratory analysis. Whereas a common aetiological risk or exposure pathway should be a linking feature of the cases that cluster, it is not possible to assess this without first establishing whether a local risk abnormality exists, however it is defined.
Interpretation of probability statements related to clusters is a further concern. Of course this aspect of cluster analysis will inevitably lead to dispute. For example, a public health department may decide based on a P-value of 0.051 (from a cluster test or model evaluation) that there is no cause to investigate the cluster further. How does one interpret such a value? Clearly there is marginal evidence for an effect, but what if the value were 0.049? There will always be disputes concerning marginal results but this does not invalidate the practice of statistical evaluation. In fact it reinforces the conclusion that the resulting evidence is truly equivocal, and this conclusion could not have been reached without statistical evaluation.
The example cited by the authors of a 'cluster' of occupational breast cancer does indeed have an issue with a reference population. However, this is not a spatial cluster example and is of limited relevance to assessment of spatial clustering as an exploratory tool in such studies. Perhaps this points to the need for sensitivity analysis to assumptions about study design and methods employed, rather than the rejection of statistical cluster testing.
Fixed (putative) sources of risk
The special case of a fixed source of risk (such as an incinerator, mobile phone mast, chimney, waste dump site, river or road) is in some ways easier to assess. Often an exposure surrogate is used to provide added evidence for a 'cluster' of unusual risk. Hence distance and/or direction from a source can be used in tests or models to assess linkage between incidence and the location. These will lead to probability statements about the linkage. The problem of competing risks is also apparent here as is the issue of background clustering. Are there other sources of risk in the vicinity and does the disease naturally cluster? These issues can be taken care of with careful generalized designs and models for background heterogeneity. Often these are Bayesian in flavour (see for example Wakefield and Morris, 5 and for reviews in chapter 9 of Elliott et al. 6 and chapter 8 of Lawson
